XML 105 R65.htm IDEA: XBRL DOCUMENT v3.8.0.1
Fair Value Disclosures on Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2017
Fair Value Disclosures on Financial Instruments  
Schedule of Fair values of Financial instruments and Classification Within the Fair value Hierarchy

                                                                                                                                                                                                

€ millions

 

Category

 

 

 

 

 

 

 

 

 

December 31, 2017

 

 

 

 

Carrying
Amount

 

Measurement Categories

 

 

 

 

 

Fair Value

 

 

 

 

 

 

At
Amortized
Cost

 

At Fair Value

 

Level 1

 

Level 2

 

Level 3

 

Total

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents1) 

 

L&R

 

4,011

 

4,011

 

 

 

 

 

 

 

 

 

 

Trade and other receivables

 

 

 

6,017

 

 

 

 

 

 

 

 

 

 

 

 

Trade receivables1)

 

L&R

 

5,810

 

5,810

 

 

 

 

 

 

 

 

 

 

Other receivables2)

 

-

 

207

 

 

 

 

 

 

 

 

 

 

 

 

Other financial assets

 

 

 

2,145

 

 

 

 

 

 

 

 

 

 

 

 

Available-for-sale financial assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt investments

 

AFS

 

39

 

 

 

39

 

39

 

 

 

 

 

39

Equity investments

 

AFS

 

827

 

 

 

827

 

87

 

8

 

732

 

827

Investments in associates2)

 

-

 

32

 

 

 

 

 

 

 

 

 

 

 

 

Loans and other financial receivables

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial instruments related to employee benefit plans2)

 

-

 

155

 

 

 

 

 

 

 

 

 

 

 

 

Other loans and other financial receivables

 

L&R

 

899

 

899

 

 

 

 

 

899

 

 

 

899

Derivative assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Designated as hedging instrument

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FX forward contracts

 

-

 

29

 

 

 

29

 

 

 

29

 

 

 

29

Interest rate swaps

 

-

 

24

 

 

 

24

 

 

 

24

 

 

 

24

Not designated as hedging instrument

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FX forward contracts

 

HFT

 

41

 

 

 

41

 

 

 

41

 

 

 

41

Call options for share-based payments

 

HFT

 

90

 

 

 

90

 

 

 

90

 

 

 

90

Call option on equity shares

 

HFT

 

11

 

 

 

11

 

 

 

 

 

11

 

11

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trade and other payables

 

 

 

–1,270

 

 

 

 

 

 

 

 

 

 

 

 

Trade payables1)

 

AC

 

–952

 

–952

 

 

 

 

 

 

 

 

 

 

Other payables2)

 

-

 

–318

 

 

 

 

 

 

 

 

 

 

 

 

Financial liabilities

 

 

 

–6,595

 

 

 

 

 

 

 

 

 

 

 

 

Non-derivative financial liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loans

 

AC

 

–24

 

–24

 

 

 

 

 

–24

 

 

 

–24

Bonds

 

AC

 

–5,147

 

–5,147

 

 

 

–5,335

 

 

 

 

 

–5,335

Private placements

 

AC

 

–1,130

 

–1,130

 

 

 

 

 

–1,136

 

 

 

–1,136

Other non-derivative financial liabilities

 

AC

 

–208

 

–208

 

 

 

 

 

–208

 

 

 

–208

Derivatives

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Designated as hedging instrument

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FX forward contracts

 

-

 

–1

 

 

 

–1

 

 

 

–1

 

 

 

–1

Interest rate swaps

 

-

 

–1

 

 

 

–1

 

 

 

–1

 

 

 

–1

Not designated as hedging instrument

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FX forward contracts

 

HFT

 

–84

 

 

 

–84

 

 

 

–84

 

 

 

–84

Total financial instruments, net

 

 

 

4,308

 

3,259

 

974

 

–5,209

 

–364

 

742

 

–4,830

 

 

€ millions

 

Category

 

 

 

 

 

 

 

 

 

December 31, 2016

 

 

 

 

Carrying
Amount

 

Measurement Categories

 

 

 

 

 

Fair Value

 

 

 

 

 

 

At
Amortized
Cost

 

At Fair Value

 

Level 1

 

Level 2

 

Level 3

 

Total

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents1) 

 

L&R

 

3,702

 

3,702

 

 

 

 

 

 

 

 

 

 

Trade and other receivables

 

 

 

6,050

 

 

 

 

 

 

 

 

 

 

 

 

Trade receivables1)

 

L&R

 

5,825

 

5,825

 

 

 

 

 

 

 

 

 

 

Other receivables2)

 

-

 

225

 

 

 

 

 

 

 

 

 

 

 

 

Other financial assets

 

 

 

2,482

 

 

 

 

 

 

 

 

 

 

 

 

Available-for-sale financial assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt investments

 

AFS

 

195

 

 

 

195

 

195

 

 

 

 

 

195

Equity investments

 

AFS

 

953

 

 

 

953

 

153

 

94

 

706

 

953

Investments in associates2)

 

-

 

38

 

 

 

 

 

 

 

 

 

 

 

 

Loans and other financial receivables

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial instruments related to employee benefit plans2)

 

-

 

144

 

 

 

 

 

 

 

 

 

 

 

 

Other loans and other financial receivables

 

L&R

 

956

 

956

 

 

 

 

 

956

 

 

 

956

Derivative assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Designated as hedging instrument

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FX forward contracts

 

-

 

12

 

 

 

12

 

 

 

12

 

 

 

12

Interest rate swaps

 

-

 

47

 

 

 

47

 

 

 

47

 

 

 

47

Not designated as hedging instrument

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FX forward contracts

 

HFT

 

35

 

 

 

35

 

 

 

35

 

 

 

35

Call options for share-based payments

 

HFT

 

84

 

 

 

84

 

 

 

84

 

 

 

84

Call option on equity shares

 

HFT

 

17

 

 

 

17

 

 

 

 

 

17

 

17

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trade and other payables

 

 

 

–1,408

 

 

 

 

 

 

 

 

 

 

 

 

Trade payables1)

 

AC

 

–1,016

 

–1,016

 

 

 

 

 

 

 

 

 

 

Other payables2)

 

-

 

–392

 

 

 

 

 

 

 

 

 

 

 

 

Financial liabilities

 

 

 

–8,294

 

 

 

 

 

 

 

 

 

 

 

 

Non-derivative financial liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loans

 

AC

 

–16

 

–16

 

 

 

 

 

–16

 

 

 

–16

Bonds

 

AC

 

–6,147

 

–6,147

 

 

 

–6,374

 

 

 

 

 

–6,374

Private placements

 

AC

 

–1,717

 

–1,717

 

 

 

 

 

–1,744

 

 

 

–1,744

Other non-derivative financial liabilities

 

AC

 

–219

 

–219

 

 

 

 

 

–219

 

 

 

–219

Derivatives

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Designated as hedging instrument

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FX forward contracts

 

-

 

–24

 

 

 

–24

 

 

 

–24

 

 

 

–24

Interest rate swaps

 

-

 

0

 

 

 

0

 

 

 

0

 

 

 

0

Not designated as hedging instrument

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FX forward contracts

 

HFT

 

–170

 

 

 

–170

 

 

 

–170

 

 

 

–170

Total financial instruments, net

 

 

 

2,533

 

1,369

 

1,149

 

–6,026

 

–944

 

723

 

–6,248

 

1) We do not separately disclose the fair value for cash and cash equivalents, trade receivables, and accounts payable as their carrying amounts are a reasonable approximation of their fair values.

2) Since the line items trade receivables, trade payables, and other financial assets contain both financial and non-financial assets or liabilities (such as other taxes or advance payments), the carrying amounts of non-financial assets or liabilities are shown to allow a reconciliation to the corresponding line items in the Consolidated Statements of Financial Position.

 

Schedule of Fair values of Financial Instruments Classified According to IAS 39

                                                                                                                                                                             

€ millions

 

Category

 

 

 

 

 

December 31, 2017

 

 

 

 

Carrying Amount

 

At Amortized Cost

 

At Fair Value

Financial assets

 

 

 

 

 

 

 

 

At fair value through profit or loss

 

HFT

 

141

 

 

 

141

Available-for-sale

 

AFS

 

865

 

 

 

865

Loans and receivables

 

L&R

 

10,719

 

10,719

 

 

Financial liabilities

 

 

 

 

 

 

 

 

At fair value through profit or loss

 

HFT

 

–84

 

 

 

–84

At amortized cost

 

AC

 

–7,460

 

–7,460

 

 

 

€ millions

 

Category

 

 

 

 

 

December 31, 2016

 

 

 

 

Carrying Amount

 

At Amortized Cost

 

At Fair Value

Financial assets

 

 

 

 

 

 

 

 

At fair value through profit or loss

 

HFT

 

136

 

 

 

136

Available-for-sale

 

AFS

 

1,148

 

 

 

1,148

Loans and receivables

 

L&R

 

10,484

 

10,484

 

 

Financial liabilities

 

 

 

 

 

 

 

 

At fair value through profit or loss

 

HFT

 

–170

 

 

 

–170

At amortized cost

 

AC

 

–9,115

 

–9,115

 

 

 

Summary of Valuation Techniques of Financial Instruments Measured at Fair Value on a Recurring Basis

                                                                                                                                                                                                

 

 

 

 

 

 

 

 

 

 

Type

 

Fair Value
Hierarchy

 

Determination of Fair
Value/Valuation Technique

 

Significant
Unobservable Inputs

 

Interrelationship Between
Significant Unobservable
Inputs and Fair Value
Measurement

Other financial assets

 

 

 

 

 

 

 

 

 

Debt investments

 

Level 1

 

Quoted prices in an active market

 

NA

 

NA

 

Listed equity investments

 

Level 1

 

Quoted prices in an active market

 

NA

 

NA

Level 2

 

Quoted prices in an active market deducting a discount for the disposal restriction derived from the premium for a respective put option.

 

NA

 

NA

 

 

 

 

 

 

 

 

 

 

 

Type

 

Fair Value
Hierarchy

 

Determination of Fair
Value/Valuation Technique

 

Significant
Unobservable Inputs

 

Interrelationship Between
Significant Unobservable
Inputs and Fair Value
Measurement

 

Unlisted equity investments

 

Level 3

 

Market approach. Comparable company valuation using revenue multiples derived from companies comparable to the investee.

 

Peer companies used (revenue multiples range from 3.4 to 7.8)
Revenues of investees
Discounts for lack of marketability (10% to 20%)

 

The estimated fair value would increase (decrease) if:
The revenue multiples were higher (lower)
The investees’ revenues were higher (lower)
The liquidity discounts were lower (higher).

 

 

 

 

 

Market approach. Venture capital method evaluating a variety of quantitative and qualitative factors such as actual and forecasted results, cash position, recent or planned transactions, and market comparable companies.

 

NA

 

NA

 

 

 

 

 

Last financing round valuations

 

NA

 

NA

 

 

 

 

 

Liquidation preferences

 

NA

 

NA

 

 

 

 

 

Net asset value/Fair market value as reported by the respective funds

 

NA

 

NA

 

Call options for share-based payment plans

 

Level 2

 

Monte Carlo model.
Calculated considering risk-free interest rates, the remaining term of the derivatives, the dividend yields, the share price, and the volatility of our share.

 

NA

 

NA

 

Call option on equity shares

 

Level 3

 

Market approach. Company valuation using EBITDA multiples based on actual results derived from the investee.

 

EBITDA multiples used
EBITDA of the investee

 

The estimated fair value would increase (decrease) if:
The EBITDA multiples were higher (lower)
The investees’ EBITDA were higher (lower)

 

 

 

 

 

 

 

 

 

 

 

Type

 

Fair Value
Hierarchy

 

Determination of Fair
Value/Valuation Technique

 

Significant
Unobservable Inputs

 

Interrelationship Between
Significant Unobservable
Inputs and Fair Value
Measurement

Other financial assets/ Financial liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FX forward contracts

 

Level 2

 

Discounted cash flow using par-method.
Expected future cash flows based on forward exchange rates are discounted over the respective remaining term of the contracts using the respective deposit interest rates and spot rates.

 

NA

 

NA

 

Interest rate swaps

 

Level 2

 

Discounted cash flow.
Expected future cash flows are estimated based on forward interest rates from observable yield curves and contract interest rates, discounted at a rate that reflects the credit risk of the counterparty.

 

NA

 

NA

 

Schedule of Financial Instruments Not Measured at Fair Value

                                                                                                                                                                                               

 

 

 

 

 

 

 

Type

 

Fair Value Hierarchy

 

Determination of Fair Value/Valuation Technique

Financial liabilities

 

 

 

 

 

Fixed-rate bonds (financial liabilities)

 

Level 1

 

Quoted prices in an active market

 

Fixed-rate private placements/ loans (financial liabilities)

 

Level 2

 

Discounted cash flows.
Future cash outflows for fixed interest and principal are discounted over the term of the respective contracts using the market interest rates as of the reporting date.

 

Summary of Reconciliation from the Opening to the Closing Balances Fair Values Classified as Level 3 Fair Values

                                                                                                                                                                                               

€ millions

2017

 

2016

Unlisted Equity Investments and Call
Options on Equity Shares

 

Unlisted Equity Investments and Call
Options on Equity Shares

January 1

 

722

 

568

Transfers

 

 

 

 

Into Level 3

 

0

 

18

Out of Level 3

 

–100

 

–18

Purchases

 

257

 

156

Sales

 

–102

 

–168

Gains/losses

 

 

 

 

Included in financial income, net in profit and loss

 

26

 

96

Included in available-for-sale financial assets in other comprehensive income

 

28

 

48

Included in exchange differences in other comprehensive income

 

–89

 

22

December 31

 

 

 

742

 

722

Change in unrealized gains/losses in profit and loss for equity investments held at the end of the reporting period

 

0

 

0